Quarterly cash costs for FY2017 were:
1Q17 Sep16 $5.53M
2Q17 Dec16 $8.42M
3Q17 Mar17 $11.86M
4Q17 Jun17 $XM ???
A considerable ramp up of product manufactured and shipped, by a factor of 7, has been reported since the beginning of 3Q17.
The $XM figure will need to include costs associated with this ramp up. If run-rate cash neutrality has been achieved at the end of 4Q17, then the corresponding cash receipts required to approximately match $XM can hardly be in the single figures.
- Forums
- ASX - By Stock
- AJX
- Q4 cash receipts
Q4 cash receipts, page-29
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AJX (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.73M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.0¢ | $15.48K | 1.544M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1535721 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 94595 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1535721 | 0.010 |
6 | 519629 | 0.009 |
3 | 610000 | 0.008 |
2 | 240000 | 0.007 |
3 | 516888 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 94595 | 2 |
0.012 | 163531 | 4 |
0.014 | 137511 | 2 |
0.015 | 129929 | 2 |
0.016 | 5328505 | 2 |
Last trade - 14.01pm 12/11/2024 (20 minute delay) ? |
Featured News
AJX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online